Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2006 1
2008 2
2010 1
2011 1
2012 1
2013 2
2014 1
2015 1
2016 1
2017 2
2018 10
2019 8
2020 6
2021 5
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.
Diab A, Gogas H, Sandhu S, Long GV, Ascierto PA, Larkin J, Sznol M, Franke F, Ciuleanu TE, Pereira C, Muñoz Couselo E, Bronzon Damian F, Schenker M, Perfetti A, Lebbe C, Quéreux G, Meier F, Curti BD, Rojas C, Arriaga Y, Yang H, Zhou M, Ravimohan S, Statkevich P, Tagliaferri MA, Khushalani NI. Diab A, et al. Among authors: arriaga y. J Clin Oncol. 2023 Oct 20;41(30):4756-4767. doi: 10.1200/JCO.23.00172. Epub 2023 Aug 31. J Clin Oncol. 2023. PMID: 37651676 Free PMC article. Clinical Trial.
Reply by Authors.
Margulis V, Puligandla M, Trabulsi EJ, Plimack ER, Kessler ER, Matin SF, Godoy G, Alva A, Hahn NM, Carducci MA, Hoffman-Censits J; Collaborators. Margulis V, et al. J Urol. 2020 Apr;203(4):697-698. doi: 10.1097/JU.0000000000000644.02. Epub 2020 Jan 22. J Urol. 2020. PMID: 31967495 No abstract available.
Artificial intelligence in oncology: Path to implementation.
Chua IS, Gaziel-Yablowitz M, Korach ZT, Kehl KL, Levitan NA, Arriaga YE, Jackson GP, Bates DW, Hassett M. Chua IS, et al. Among authors: arriaga ye. Cancer Med. 2021 Jun;10(12):4138-4149. doi: 10.1002/cam4.3935. Epub 2021 May 7. Cancer Med. 2021. PMID: 33960708 Free PMC article. Review.
Reply.
Woldu SL, Bagrodia A, Moore JA, Arriaga Y. Woldu SL, et al. Among authors: arriaga y. Urology. 2018 Feb;112:111. doi: 10.1016/j.urology.2017.08.061. Epub 2017 Dec 6. Urology. 2018. PMID: 29198421 No abstract available.
A Narrative Review of Emerging Therapeutics for COVID-19.
Willis VC, Arriaga Y, Weeraratne D, Reyes F, Jackson GP. Willis VC, et al. Among authors: arriaga y. Mayo Clin Proc Innov Qual Outcomes. 2020 Dec;4(6):745-758. doi: 10.1016/j.mayocpiqo.2020.07.004. Epub 2020 Jul 20. Mayo Clin Proc Innov Qual Outcomes. 2020. PMID: 32838206 Free PMC article. Review.
Rapid review: Identification of digital health interventions in atherosclerotic-related cardiovascular disease populations to address racial, ethnic, and socioeconomic health disparities.
Thomas Craig KJ, Fusco N, Lindsley K, Snowdon JL, Willis VC, Arriaga YE, Dankwa-Mullan I. Thomas Craig KJ, et al. Among authors: arriaga ye. Cardiovasc Digit Health J. 2020 Nov 6;1(3):139-148. doi: 10.1016/j.cvdhj.2020.11.001. eCollection 2020 Nov-Dec. Cardiovasc Digit Health J. 2020. PMID: 35265886 Free PMC article. Review.
39 results